| Inflammatory | Cardiac sarcoidosis (granulomatous myocarditis) Giant cell myocarditis Immune check-point inhibitor myocarditis Lymphocytic myocarditis Eosinophilic myocarditis |
| Genetic | Arrhythmogenic cardiomyopathy Lamin A/C cardiomyopathy Noncompaction cardiomyopathy End-stage hypertrophic cardiomyopathy |
| Infectious | Chagas disease (Trypanosoma cruzi) Lyme carditis (Borrelia burgdorferi) |
| Metabolic | Cardiac iron overload, including hereditary hemochromatosis |
| Infiltrative | Amyloid Glycogen storage disease (i.e. Fabry’s) Hydroxychloroquine mediated cardiomyopathy |
| Inflammatory | Cardiac sarcoidosis (granulomatous myocarditis) Giant cell myocarditis Immune check-point inhibitor myocarditis Lymphocytic myocarditis Eosinophilic myocarditis |
| Genetic | Arrhythmogenic cardiomyopathy Lamin A/C cardiomyopathy Noncompaction cardiomyopathy End-stage hypertrophic cardiomyopathy |
| Infectious | Chagas disease (Trypanosoma cruzi) Lyme carditis (Borrelia burgdorferi) |
| Metabolic | Cardiac iron overload, including hereditary hemochromatosis |
| Infiltrative | Amyloid Glycogen storage disease (i.e. Fabry’s) Hydroxychloroquine mediated cardiomyopathy |
| Inflammatory | Cardiac sarcoidosis (granulomatous myocarditis) Giant cell myocarditis Immune check-point inhibitor myocarditis Lymphocytic myocarditis Eosinophilic myocarditis |
| Genetic | Arrhythmogenic cardiomyopathy Lamin A/C cardiomyopathy Noncompaction cardiomyopathy End-stage hypertrophic cardiomyopathy |
| Infectious | Chagas disease (Trypanosoma cruzi) Lyme carditis (Borrelia burgdorferi) |
| Metabolic | Cardiac iron overload, including hereditary hemochromatosis |
| Infiltrative | Amyloid Glycogen storage disease (i.e. Fabry’s) Hydroxychloroquine mediated cardiomyopathy |
| Inflammatory | Cardiac sarcoidosis (granulomatous myocarditis) Giant cell myocarditis Immune check-point inhibitor myocarditis Lymphocytic myocarditis Eosinophilic myocarditis |
| Genetic | Arrhythmogenic cardiomyopathy Lamin A/C cardiomyopathy Noncompaction cardiomyopathy End-stage hypertrophic cardiomyopathy |
| Infectious | Chagas disease (Trypanosoma cruzi) Lyme carditis (Borrelia burgdorferi) |
| Metabolic | Cardiac iron overload, including hereditary hemochromatosis |
| Infiltrative | Amyloid Glycogen storage disease (i.e. Fabry’s) Hydroxychloroquine mediated cardiomyopathy |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
